Evidence map›Paper›PMID 41066315›Full record

ArticlePloS one2025

PRMT5 genetic interactions with DNA double strand break repair genes.

Hunter J Bliss, Juliana Tron, Wesley Bush, Renee A Bouley, Ruben C Petreaca

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hunter J BlissBiology Program, The Ohio State University, Marion, Ohio, United States of America.
Juliana TronBiology Program, The Ohio State University, Marion, Ohio, United States of America.
Wesley BushBiology Program, The Ohio State University, Marion, Ohio, United States of America.
Renee A BouleyDepartment of Chemistry and Biochemistry, The Ohio State University, Marion, Ohio, United States of America.
Ruben C PetreacaThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.ORCID https://orcid.org/0000-0002-9752-8500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein arginine methyltransferase 5 (PRMT5) has pleiotropic functions in human cells but also participates in orchestrating DNA double strand break (DSB) repair. It methylates the TIP60 histone acetyltransferase complex to facilitate recruitment to the DSB and chromatin remodeling. PRMT5 mutations affect DSB repair by homologous recombination and increase chromosomal instability. In this report we characterized genetic interactions between PRMT5 mutations and mutations in other components of DSB repair pathway. We used data deposited on the Catalogue of Somatic Mutations in Cancers (COSMIC). We found that PRMT5 makes negative genetic interactions with TIP60 and member of the 9-1-1 complex (RAD9, RAD1, HUS1) which is required for checkpoint activation. A comprehensive analysis of all cancer data deposited on COSMIC reveals very few samples with mutations in both PRMT5 and TIP60 or components of the 9-1-1 complex in samples where mutations in other DNA damage repair genes occur (e.g., MRN, checkpoint genes, etc). This suggests that when more factors of the DNA damage repair machinery are destabilized, the functions of TIP60 and 9-1-1 appear to become essential. Protein 3-D structure analysis shows that mutations affect protein-protein interactions that may destabilize 9-1-1 or TIP60 complex formation. These data highlight interesting interactions between the various genetic pathways governing DSB repair. It also reveals potential therapeutic targets. For example, inhibition of the 9-1-1 complex in a PRMT5 mutant may selectively kill the cell. Given that PRMT5 small molecule inhibitors are being developed or already deployed, these findings should inform potential applications of these drugs.

Indexed as

DNA Breaks, Double-StrandedDNA RepairEpistasis, GeneticProtein-Arginine N-MethyltransferasesHumansLysine Acetyltransferase 5MutationKAT5 protein, humanLysine Acetyltransferase 5PRMT5 protein, humanProtein-Arginine N-Methyltransferases

Identifiers

PMID41066315
PMCPMC12510555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.